Persistent Circulating Tumor Cells at One Year after Oncologic Resection Predict Late Recurrence in Pancreatic Cancer.
Ammar Asrar JavedDing DingAlina HasanainFloortje van OostenJun YuJohn L CameronRichard A BurkhartLei ZhengJin HeChristopher L WolfgangPublished in: Annals of surgery (2022)
In patients deemed to be clinically disease free 12 months postoperatively, trCTCs positivity is associated with higher rates of subsequent recurrence with distinct patterns of recurrence. CTCs could be used a putative biomarker to guide patient prognostication and management in pancreatic cancer.